BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics
Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at
the 37th Annual J.P. Morgan Healthcare Conference in
San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time.
The public may access Mr. Simon's presentation live via webcast
at:
https://jpmorgan.metameetings.net/events/healthcare19/sessions/23877-haemonetics-corporation/webcast
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated
to providing a suite of innovative hematology products and
solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technologies address important
medical markets: blood and plasma component collection, the
surgical suite, and hospital transfusion services. To learn more
about Haemonetics, visit http://www.haemonetics.com.
INVESTOR
CONTACTS:
|
MEDIA
CONTACT:
|
Gerry Gould,
VP-Investor Relations
|
Carla Burigatto,
VP-Communications
|
(781)
356-9402
|
(781)
348-7263
|
gerry.gould@haemonetics.com
|
carla.burigatto@haemonetics.com
|
|
|
Olga Vlasova, Sr.
Mgr.-Investor Relations
|
|
(781)
356-9763
|
|
olga.vlasova@haemonetics.com
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-37th-annual-jp-morgan-healthcare-conference-300769142.html
SOURCE Haemonetics Corporation